Attorney Advertising · The Alvarez Law Firm · Coral Gables, FL
Exposure to harmful chemicals — in drinking water, herbicides, firefighting foam, medications, and consumer products — has been linked to cancer and other serious health conditions. When companies and government agencies fail to warn the public, they can be held responsible. Browse every active toxic exposure case below.
These toxic exposure cases are still actively accepting claims.
Farmers, agricultural workers, and others regularly exposed to paraquat — a widely used herbicide — have alleged that prolonged exposure caused them to develop Parkinson’s disease. Paraquat is banned in more than 30 countries but still permitted in the United States.
Aqueous film-forming foam (AFFF) used by military and civilian firefighters contains PFAS chemicals linked to several types of cancer. Firefighters and military personnel who used AFFF at training facilities and airports have filed lawsuits alleging they developed cancer as a result.
From 1953 to 1987, Marines, their families, and civilian workers at Camp Lejeune in North Carolina drank water contaminated with industrial solvents and other toxic chemicals. Exposure has been linked to multiple cancers and serious illnesses. The PACT Act opened a pathway for claims.
Women who used Johnson’s Baby Powder and other talc-based products over many years have filed lawsuits alleging that the talcum powder caused ovarian cancer or mesothelioma. Johnson & Johnson faces ongoing litigation over these claims.
These cases have resulted in settlement funds. Some are still processing payments; others have paid out.
Bayer has paid more than $10.9 billion to resolve Roundup cancer cases to date. A proposed new $7.25 billion deal would cover existing and future non-Hodgkin lymphoma cases for 21 years. Individual claims are still being filed and accepted. Important opt-out deadline: June 4, 2026.
3M agreed to pay up to $12.5 billion and DuPont agreed to pay $1.185 billion to resolve claims from water utilities contaminated by PFAS “forever chemicals.” Individual exposure claims for people diagnosed with cancer or other PFAS-linked conditions are also being filed.
The FDA pulled Zantac from the market in 2020 after discovering that ranitidine, the active ingredient, could degrade into NDMA — a probable human carcinogen. People who took Zantac long-term and later developed cancer have filed lawsuits.